Long-Term Clopidogrel Therapy in Patients Receiving Percutaneous Coronary Intervention

被引：0
|
作者：
Bart M. S. Heeg
Ron J. G. Peters
Marc Botteman
Ben A. van Hout
机构：
[1] Pharmerit International,Department of Cardiology
[2] Academic Medical Centre,undefined
[3] Pharmerit International,undefined
来源：
PharmacoEconomics | 2007年 / 25卷
关键词：
Percutaneous Coronary Intervention; Clopidogrel; Clopidogrel Therapy; Elective Percutaneous Coronary Intervention; Deterministic Sensitivity Analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: The PCI-CURE (Percutaneous Coronary Intervention-Clopidogrel in Unstable Angina to Prevent Recurrent Events) and CREDO (Clopidogrel for the Reduction of Events During Observation) studies have demonstrated that, in addition to aspirin, pre-treatment with clopidogrel followed by long-term (i.e. 9—12 months) therapy significantly reduces the risk of atherothrombotic events in patients undergoing percutaneous coronary intervention (PCI).
引用
收藏
页码：769 / 782
页数：13
相关论文
共 50 条
  • [41] Rate of percutaneous coronary intervention and long-term mortality in patients with vasospastic angina
    Yoon, S. G.
    Seung, K. B.
    Kim, B. J.
    Baek, J. Y.
    Park, M. W.
    Jung, H. U.
    Chang, K. Y.
    Shin, D. I.
    Shin, W. S.
    Kim, D. B.
    Hur, S. H.
    Baek, S. H.
    Kim, J. H.
    Choi, K. B.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (8B): : 83C - 84C
  • [42] Association of Frailty With In-hospital and Long-term Outcomes Among STEMI Patients Receiving Primary Percutaneous Coronary Intervention
    Hosseini, Farshad
    Pitcher, Ian
    Kang, Mehima
    Mackay, Martha
    Singer, Joel
    Lee, Terry
    Madden, Kenneth
    Cairns, John A.
    Wong, Graham C.
    Fordyce, Christopher B.
    CJC OPEN, 2024, 6 (08) : 1004 - 1012
  • [43] Long-term outcome after percutaneous coronary intervention in patients with essential thrombocythemia
    Campo, G.
    Valgimigli, M.
    Carletti, R.
    Fileti, L.
    Ferrari, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (07) : 1235 - 1238
  • [44] Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention
    Anderson, KM
    Califf, RM
    Stone, GW
    Neumann, FJ
    Montalescot, G
    Miller, DP
    Ferguson, JJ
    Willerson, JT
    Weisman, HF
    Topol, EJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (08) : 2059 - 2065
  • [45] Long-term outcome of patients with APLA syndrome undergoing percutaneous coronary intervention
    Lev, E.
    Netzer, A.
    Rechavia, E.
    Bental, T.
    Codner, P.
    Assali, A.
    Battler, A.
    Kornowski, R.
    EUROPEAN HEART JOURNAL, 2011, 32 : 992 - 992
  • [46] Long-term outcomes of patients with mitral regurgitation undergoing percutaneous coronary intervention
    Pastorius, Catherine A.
    Henry, Timothy D.
    Harris, Kevin M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (08): : 1218 - 1223
  • [47] 9301 cost-effectiveness of long-term therapy with clopidogrel following percutaneous coronary intervention:: A Swedish analysis of the CREDO-trial
    Ringborg, A
    Lindgren, P
    Jönsson, B
    VALUE IN HEALTH, 2005, 8 (03) : 253 - 253
  • [48] Hypertension and chronic kidney disease affect long-term outcomes in patients with stable coronary artery disease receiving percutaneous coronary intervention
    Mao-Jen Lin
    Wen-Chieh Yang
    Chun-Yu Chen
    Chia-Chen Huang
    Hsun-Yang Chuang
    Feng-Xia Gao
    Han-Ping Wu
    Scientific Reports, 8
  • [49] Hypertension and chronic kidney disease affect long-term outcomes in patients with stable coronary artery disease receiving percutaneous coronary intervention
    Lin, Mao-Jen
    Yang, Wen-Chieh
    Chen, Chun-Yu
    Huang, Chia-Chen
    Chuang, Hsun-Yang
    Gao, Feng-Xia
    Wu, Han-Ping
    SCIENTIFIC REPORTS, 2018, 8
  • [50] Switching from clopidogrel to prasugrel resolves vascular inflammation in patients receiving long-term aspirin plus clopidogrel therapy after coronary stent implantation
    Bekki, Munehisa
    Tahara, Nobuhiro
    Tahara, Atsuko
    Maeda-Ogata, Shoko
    Sugiyama, Yoichi
    Honda, Akihiro
    Igata, Sachiyo
    Harada, Atsushi
    Hirakawa, Yuji
    Kurata, Seiji
    Fujimoto, Kiminori
    Abe, Toshi
    Fukumoto, Yoshihiro
    Ueno, Takafumi
    JOURNAL OF NUCLEAR CARDIOLOGY, 2021, 28 (03) : 1191 - 1192
12345